Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of July 30, 2026, MGRX trades at $0.42 with a market cap of $9.55M and a P/E ratio of -0.25. MGRX moved -24.91% today. Year to date, MGRX is -25.31%; over the trailing twelve months it is -66.09%. Its 52-week range spans $0.16 to $6.15. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MGRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.42 |
| Market Cap | $9.55M |
| P/E Ratio | -0.25 |
| EPS | $-2.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.15 |
| 52-Week Low | $0.16 |
| Volume | 7.32M |
| Avg Volume | 0 |
| Revenue (TTM) | $456.02K |
| Net Income | $-20.64M |
| Gross Margin | 54.91% |
MGRX analyst coverage data. Average price target: $0.00.